
The article argues for buying Joby Aviation over Archer Aviation, citing Joby’s lead in eVTOL execution: 50,000+ test-flight miles and progress through the FAA certification process, including flying its first FAA-conforming production aircraft. Joby is positioned with about $1.1B in cash/cash equivalents/investments as of Q1 2026, versus Archer’s roughly $1.7B, but Archer is flagged as facing higher commercialization risk due to dependency on FAA certification, manufacturing scale-up, charging infrastructure, and delayed partner-driven economics. Overall, the piece suggests Joby has a higher probability of success and lower near-term dilution risk, while Archer remains a watchlist.
The cleanest read here is not “eVTOL wins,” but a widening gap between credible certification progress and marketing-driven optionality. In a pre-revenue category, the stock that benefits most is the one that can reduce financing risk before commercialization: that supports JOBY’s multiple versus ACHR because each incremental FAA milestone de-risks dilution and lowers the cost of capital. DAL, UAL, and possibly UBER gain only as distribution/booking layers if early routes work; the real economic value will accrue to whoever controls customer acquisition and utilization, not just aircraft assembly.
The second-order loser is any partner-heavy model that cedes operating economics. If commercialization starts slowly, ACHR’s reliance on external partners can become a margin and timeline headwind because it has less control over route density, maintenance learning curves, and pricing. That also means the market may be underestimating how quickly “good partnerships” can turn into balance-sheet pressure if manufacturing ramps before demand is proven.
Near term, the catalyst path is binary and policy-driven: FAA progress, conformity testing, and initial market approvals over the next 1-3 months matter far more than press-release partnerships. Over 6-18 months, the key question is whether either company can convert regulatory progress into repeatable utilization without another funding round. The thesis is falsified by certification slippage, a need to raise capital on weak terms, or evidence that early customers are pilot projects rather than real demand. Contrarian view: JOBY’s lead is real, but the market may already be paying for an execution path that still has multiple failure points; ACHR is weaker, yet could outperform on sentiment if it becomes the cheaper, more crowded short.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment